Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772602 · ClinicalTrials.gov registry record
The National Amyotrophic Lateral Sclerosis Registry
A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Centers for Disease Control and Prevention.
- Recruiting
- Registry status
- 30,000
- Enrollment target
- 1
- Study location
NCT01772602: Recruiting study of Amyotrophic Lateral Sclerosis, sponsored by Centers for Disease Control and Prevention.
NCT01772602 is a study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Centers for Disease Control and Prevention. The registered enrollment target is 30,000 participants, above the 604-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (4867% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01772602, a study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Centers for Disease Control and Prevention.
- RECRUITING
- Registry status
- 30,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.
Primary Outcome
To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.
Conditions Studied
Study Locations (1)
Georgia
- CDC - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2010-10 |
| Est. Completion | 2040-12 |
What NCT01772602 shows while recruiting
NCT01772602 is an observational study that tracks outcomes without assigning an intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 604-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (4867% higher).
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT01772602 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01772602 about?
NCT01772602 is a clinical study titled "The National Amyotrophic Lateral Sclerosis Registry". The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors...
What is the current status of trial NCT01772602?
This trial is currently recruiting. The enrollment target is 30,000 participants. The study started on 2010-10. Estimated completion is 2040-12.
What conditions does trial NCT01772602 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
Who is sponsoring clinical trial NCT01772602?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01772602 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01772602's enrollment target sits among peer trials
30,000 1st of 102 higher than 102 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia